INY-03-041 trihydrochloride

Biorbyt

INY-03-041 trihydrochloride

10

Research Use Only

98.00%

C44H59Cl4N7O5

907.8

INY-03-041 trihydrochloride, a potent and highly selective PROTAC-based pan-AKT degrader, comprises Ipatasertib, an ATP-competitive AKT inhibitor, conjugated to Lenalidomide. It effectively inhibits AKT1, AKT2, and AKT3 with IC50 values of 2.0, 6.8, and 3.5 nM, respectively [1].

-20°C

12352200